Insider Trading Activity For HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
Holdings A/S Novo , Major Shareholder of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) reportedly Sold 382,437 shares of the company’s stock at an average price of 1.91 for a total transaction amount of $730,454.67 SEC Form
Insider Trading History For HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
Analyst Ratings For HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
These are 1 Hold Rating, 2 Buy Ratings .
The current consensus rating for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is Buy (Score: 2.67) with a consensus target price of $6.17 , a potential (224.56% upside)
Analyst Ratings History For HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
- On 3/28/2016 Leerink Swann Reiterated Rating Outperform with a price target of $10.00 to $5.00
- On 4/19/2017 Canaccord Genuity Boost Price Target of rating Hold with a price target of $5.50 to $6.50
- On 5/16/2017 Rodman & Renshaw Boost Price Target of rating Buy to Buy with a price target of $4.50 to $6.00
- On 8/9/2017 HC Wainwright Set Price Target of rating Buy with a price target of $6.00
Recent Trading Activity for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
Shares of HTG Molecular Diagnostics, Inc. closed the previous trading session at 1.90 down -0.09 -4.52% with 1,173,177 shares trading hands.